Targeting d-Amino Acid Oxidase (DAAO) for the Treatment of Schizophrenia: Rationale and Current Status of Research Chien-Yi KuoChieh-Hsin LinHsien-Yuan Lane Leading Article 04 October 2022 Pages: 1143 - 1153
The Efficacy and Safety of Anti-CD20 Antibody Treatments in Relapsing Multiple Sclerosis: A Systematic Review and Network Meta-analysis Xin WuXin TanZhong Wang Systematic Review 16 October 2022 Pages: 1155 - 1170
Clinical Effectiveness of Muscarinic Receptor-Targeted Interventions in Neuropsychiatric Disorders: A Systematic Review Shivani VaidyaAlexandre A. GuerinAndrew J. Lawrence Systematic Review Open access 21 October 2022 Pages: 1171 - 1206
The Safety of Deutetrabenazine for Chorea in Huntington Disease: An Open-Label Extension Study Samuel FrankClaudia TestaThe Huntington Study Group/ARC-HD Investigators and Coordinators Original Research Article Open access 15 October 2022 Pages: 1207 - 1216
The XINDI Study: A Randomized Phase III Clinical Trial Evaluating the Efficacy and Safety of Safinamide as Add-On Therapy to Levodopa in Chinese Patients with Parkinson’s Disease with Motor Fluctuations Qianqian WeiYuyan Tanthe XINDI Study Investigators Group Original Research Article Open access 08 November 2022 Pages: 1217 - 1227
Dextromethorphan/Bupropion: First Approval Susan J. Keam AdisInsight Report 27 October 2022 Pages: 1229 - 1238
Correction to: Inebilizumab: A Review in Neuromyelitis Optica Spectrum Disorder Tina NieHannah A. Blair Correction Open access 03 October 2022 Pages: 1239 - 1239
Correction to: The Impact of Lithium on Brain Function in Bipolar Disorder: An Updated Review of Functional Magnetic Resonance Imaging Studies Emilio BergamelliLorenzo Del FabroPaolo Brambilla Correction Open access 07 October 2022 Pages: 1241 - 1241
